Your session is about to expire
← Back to Search
Observational for Bladder Cancer
N/A
Recruiting
Led By Mark D. Tyson, M.D., M.P.H.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at baseline, 6, 12, 24, and 36 months
Awards & highlights
Study Summary
This study evaluates the effect of bladder cancer treatment on quality of life.
Eligible Conditions
- Bladder Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at baseline, 6, 12, 24, and 36 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at baseline, 6, 12, 24, and 36 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in quality of life outcomes - Bladder Cancer Index
Change in quality of life outcomes - PROMIS-29
Patient level characteristics
Trial Design
1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Patients complete surveys and also have their medical records reviewed on study.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,209 Previous Clinical Trials
3,766,430 Total Patients Enrolled
Mark D. Tyson, M.D., M.P.H.Principal InvestigatorMayo Clinic
1 Previous Clinical Trials
107 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger